Kasim, Rica .
HRN: 27-00-65 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/22/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/22/2025
04/30/2025
IV
400mg
Q8h
Osteomyelitis
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes